These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2360913)

  • 1. On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the rat.
    Balasubramaniam S; Simons LA; Chang S; Roach PD; Nestel PJ
    Atherosclerosis; 1990 May; 82(1-2):1-5. PubMed ID: 2360913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
    Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
    Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
    Purdy BH; Field FJ
    J Clin Invest; 1984 Aug; 74(2):351-7. PubMed ID: 6746898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA; Toaff ME; Strauss JF
    Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hypothyroidism and thyroxine replacement on hepatic and intestinal HMG-CoA reductase and ACAT activities and biliary lipids in the rat.
    Field FJ; Albright E; Mathur SN
    Metabolism; 1986 Dec; 35(12):1085-9. PubMed ID: 3784912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the intestinal acyl-CoA:cholesterol acyltransferase activity in the hyperresponse of diabetic rats to dietary cholesterol.
    Maechler P; Wollheim CB; Bentzen CL; Niesor E
    J Lipid Res; 1992 Oct; 33(10):1475-84. PubMed ID: 1431572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats.
    LeBlanc MJ; Brunet S; Bouchard G; Lamireau T; Yousef IM; Gavino V; Lévy E; Tuchweber B
    J Nutr Biochem; 2003 Jan; 14(1):40-8. PubMed ID: 12559476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption.
    Largis EE; Wang CH; DeVries VG; Schaffer SA
    J Lipid Res; 1989 May; 30(5):681-90. PubMed ID: 2760542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic cholesterol and lipoprotein metabolism in ethinyl estradiol-treated rats.
    Erickson SK; Jaeckle S; Lear SR; Brady SM; Havel RJ
    J Lipid Res; 1989 Nov; 30(11):1763-71. PubMed ID: 2614275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hepatic and intestinal cholesterol regulatory enzymes. The influence of metformin.
    Scott LM; Tomkin GH
    Biochem Pharmacol; 1983 Mar; 32(5):827-30. PubMed ID: 6838630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol metabolism in alloxan-induced diabetic rabbits.
    O'Meara NM; Devery RA; Owens D; Collins PB; Johnson AH; Tomkin GH
    Diabetes; 1990 May; 39(5):626-33. PubMed ID: 2332120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
    Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
    Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared effect of n-3 and n-6 dietary fatty acids on rat intestinal acyl-CoA:cholesterol acyltransferase activity.
    Chautan M; Termine E; Amirayan N; Leonardi J; Pauli AM; Portugal H; Lafont H
    Scand J Gastroenterol; 1989 Jun; 24(5):632-40. PubMed ID: 2762765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.